OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 95 filers reported holding OVID THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $317,909 | +23.0% | 82,791 | +5.1% | 0.00% | – |
| Q2 2023 | $258,359 | +31.1% | 78,768 | +60.8% | 0.00% | – |
| Q1 2021 | $197,000 | +71.3% | 48,990 | -1.4% | 0.00% | – |
| Q4 2020 | $115,000 | -56.8% | 49,670 | +7.3% | 0.00% | – |
| Q3 2020 | $266,000 | -25.1% | 46,280 | -4.0% | 0.00% | -100.0% |
| Q2 2020 | $355,000 | +1083.3% | 48,225 | +183.5% | 0.00% | – |
| Q1 2019 | $30,000 | -25.0% | 17,010 | +2.8% | 0.00% | – |
| Q4 2018 | $40,000 | -37.5% | 16,551 | +47.2% | 0.00% | – |
| Q3 2018 | $64,000 | -30.4% | 11,241 | -4.9% | 0.00% | – |
| Q2 2018 | $92,000 | – | 11,816 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |